baber/WOPTO huggingface dataset:
Patent AU-2003229563-A1 (AU)
Title: Hybrid system for solubilizing pharmaceutically active substances in polymer matrices
Inventor: NIERLE JENS
IPC: A61K9/70
Filed: 2003-03-21
Abstract: The present invention is directed to a hybridized polymer matrix, a method of making such, and products incorporating such a matrix. The hybridized polymer matrix comprises a solvent-free polymer matrix base, a hybridized matrix comprising one or more poly(1-vinyl-2-pyrrolidones) and dimethyl sulfoxide, and at least one active substance. The hybridized polymer matrix is useful in the preparation of transdermal therapeutic systems, particularly making possible the introduction of pharmaceutically active substances which are otherwise difficult to dissolve, such as ibuprofen, into a non-polar matrix.
Patent AU-2003240398-A1 (AU)
Title: Surgical instrument.
Inventor: FUCHS ERNST
IPC: A61C8/00
Filed: 2003-04-16
Abstract: A surgical instrument for preparing implant beds in a lower jaw of a patient, which includes a drilling element with a spinous configuration and a handle fixed to the drilling element. The drilling element has a truncated cone having an outer surface line which forms a maximum angle of several degrees with the axis of the truncated cone, the outer surface of which is smooth. The handle is positioned at an angle in relation to the axis of the truncated cone.
Patent AU-2003251090-A1 (AU)
Title: Anticollision method comprising time-slots processing information that marks the time slots
Inventor: SCHERABON CHRISTIAN
IPC: H04L1/00
Filed: 2003-07-18
Abstract: During the implementation of an anticollision method by a reader station (1) to identify all data carriers (2, 3, 4) in the communication field (HF), in order to shorten the time slots (S) in which none of the data carriers (2, 3, 4) is responding or in which a collision of multiple responses from the data carriers (2, 3, 4) occurs, a time-slot progressing information (ZWI) is sent by the reader station (1). The time-slot progressing information (ZWI) contains a time-slot number (ZN), which identifies the time slot (Si) next in line after the current time slot (S).
Patent AU-2003256954-A1 (AU)
Title: Spectroscopic unwanted signal filters for discrimination of vulnerable plaque and method therefor
Inventor: MARSHIK-GEURTS J BARBARA
IPC: A61B5/02
Filed: 2003-07-29
Abstract: Spectral variation contributed from the absorbance of unwanted correlated signals, such as blood at variable pathlengths between an in vivo catheter optic probe and a coronary vessel wall is an obstacle in the detection of vulnerable plaque. Preprocessing methods are described to reduce the impact of blood upon the spectral signal, based on the principles of Orthogonal Subspace Projection (OSP) and Generalized Least Square (GLS). The multivariate discrimination models used on the processed spectral information reduce the number of independent factors that include contributions from blood. The disclosed chemometric processing including preprocessing methods provide for in vivo spectral detection of medical analytes within the human body and in particular within the coronary vessel wall. A demonstration of how the preprocessing methods impact a discrimination modeling technique is provided, how the blood filters were developed and optimized, and finally how the OSP and GLS blood filters correct the spectral signal and improve the discrimination results of the models.
Patent AU-2003278896-A1 (AU)
Title: Dichloroacetate in combination with cardioprotective or hemodynamic drugs
Inventor: LOPASCHUK GARY D
IPC: A61K31/137
Filed: 2003-06-20
Abstract: The present invention provides compositions and methods for using cardioprotective or hemodynamic drugs in combination with dichloroacetate enabling usage of cardioprotective or hemodynamic drugs at concentrations higher than used in normal clinical practice without increasing deleterious side effects normally associated with the cardioprotective or hemodynamic drug, thereby conferring added clinical benefit. The present invention teaches administration of DCA with cardioprotective or hemodynamic drugs as an adjunct therapy thereby conferring added clinical benefit to clinically recommended protocols.
Patent AU-2003288243-A1 (AU)
Title: Ball pin and ball joint comprising one such ball pin
Inventor: EGNER-WALTER BRUNO
IPC: F16C11/06
Filed: 2003-12-09
Abstract: A ball pin comprising a ball and a pin connected to the ball is characterized in that the ball is provided with a recess on its side facing away from the pin, the diameter of said recess corresponding approximately to the diameter of the pin.
Patent AU-2003288803-A1 (AU)
Title: A device for condensing volatile organic compounds from a storage or transport tank into oil
Inventor: LOTHE PER
IPC: B65D90/30
Filed: 2003-12-22
Abstract: A device for condensing volatile organic compounds (VOC) from a storage or transport tank (4) into oil from the same or another storage or transport tank (4) via a downcomer (6), where the upper part (8) of the downcomer (6), which upper part has a cross sectional area that is essentially unreduced, is connected to a gas pipe (14), the gas pipe (14) communicating with the upper part (16) of the storage or transport tank (4), and where the upper part (8) of the downcomer (6) is arranged at a sufficient height above the upper part (16) of the storage or transport tank (4) to cause an inflow of gas from the upper part (16) of the storage or transport tank (4) due to the underpressure created in the upper part (8) of the downcomer (6) when oil flows down through the downcomer (6).
Patent AU-2003295045-A1 (AU)
Title: Contact device for improving lifetime of electrical connections
Inventor: PILLET MICHEL
IPC: H01R4/34
Filed: 2003-11-20
Abstract: The improved life contact mechanism has two conductors (21,23) with an insertion element placed between the two conductor surfaces (22,24). The insertion element (10) is electrically conducting and made of several rubber materials having porosity and high deformability reducing electrical connection resistance.
Patent AU-2003299514-A1 (AU)
Title: Process for prefiltration of a protein solution
Inventor: SIWAK MARTY
IPC: G01N1/28
Filed: 2003-05-19
Abstract: A process is provided for selectively removing plugging constituents from a biomolecule containing solution in a normal flow (NFF) filtration process before viral filtration. Preferably, it relates to a process for selectively removing plugging constituents from a biomolecule solution in a normal flow (NFF) filtration process and virus particles from the solution in a two-step filtration process. In a first step, a biomolecule solution is filtered through a filtration device containing one or more plugging constituent removing media in the form of one or more layers of adsorptive depth filters, filled microporous membranes or a small bed of media in a normal flow filtration mode of operation, to produce a plugging constituent -free stream. The plugging constituent-free stream can then be filtered through one or more ultrafiltration membranes to retain virus particles at a retention level of at least 3 LRV and to allow passage therethrough of a plugging constituent- free and virus-free biomolecule containing solution.
Patent AU-2004222348-A1 (AU)
Title: Filter media with enhanced microbiological interception capability
Inventor: KOSLOW EVAN E
IPC: B01D39/14
Filed: 2004-02-10
Abstract: The present invention is directed to a composite filter medium having a pH altering material that can raise the pH of an influent such that microbiological contaminants in the influent remain substantially negatively charged such that a positively charged medium within the composite filter medium can more effectively capture the microbiological contaminants.
Patent AU-2004255521-A1 (AU)
Title: Nozzle arrangements
Inventor: SHARIEF RAJAB
IPC: B05B7/04
Filed: 2004-07-02
Abstract: Nozzle arrangement for generating a spray of fluid comprise a body defining a flow passageway ( 10 ), which receives fluid from a supply via an inlet ( 11 or 12 ) and is configured to present a plurality of chambers ( 13, 16, 20 ) separated by constriction such as ( 15, 17 ). The chambers include expansion chambers such as ( 13, 20 ), and the constrictions may be associated with respective convergent and divergent passage sections ( 14, 19 ). The inner surfaces of the passageway or chambers, may be provide with small scale structures such as grooves, ribs, pits or protrusions.
Patent AU-2004267094-A1 (AU)
Title: (4 -amino -1,2, 5-oxadiazol-4-yl) -hetxiroaromatic compounds useful as protein kinase inhibitors
Inventor: HARBESON SCOTT L
IPC: C07D413/14
Filed: 2004-08-20
Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Patent WO-2007009150-A1 (WO)
Inventor: BAILEY MARK DAVID
IPC: A63H27/10
Filed: 2005-07-18
Abstract: A balloon holder (1) for holding decorative balloons including: a base (10) for supporting the holder on a surface; at least one wall (20) extending upwards from the base (10), and defining a chamber adapted to receive ballast material therein; a removable cap (30) attachable to the wall (20) to close the chamber; and an anchor point (40) for attaching inflated balloons thereto, said anchor point (40) located on the removable cap (30).
Patent AU-2005202197-A1 (AU)
Title: Composition for dyeing keratin fibres
Inventor: WOOD JONATHON
IPC: A61Q5/10
Filed: 2005-05-20
Abstract: This invention relates to a hair dyeing composition comprising at least one anionic and at least one cationic direct acting hair dyes and showing excellent dyeing ability and excellent resistance to hair washing and environmental influences. The colouring composition of this invention are ready to use colouring composition and, therefore, do not require any mixing prior to application with additional agents such as oxidizers. According to the invention, suitable cationic dyestuffs are of the following structure   
wherein R 1  and R 2  stand for hydrogen, a CH 3 - or C 2 H 5 - group, R 3  stands for hydrogen, -OCH 3  or -OC 2 H 5 , and Y -  is chloride, bromide, methosulfate.
Patent AU-2005275577-A1 (AU)
Title: Nutritional composition comprising immunoglobulins and oligosaccharides
Inventor: RABET LAURA M
IPC: A23L33/00
Filed: 2005-08-24
Abstract: The present invention provides a method and composition for the treatment and/or prevention of infection, said method comprising orally administering a composition to a mammal, said composition comprising a galactose containing indigestible oligosaccharide and immunoglobulin from the milk or colostrum of hyperimmunized cows.
Patent AU-2005286391-A1 (AU)
Title: Reduced sweating AZS product
Inventor: CABODI ISABELLE
IPC: C04B35/109
Filed: 2005-09-14
Abstract: An AZS type fused cast refractory product presenting the following chemical composition, as a percentage by weight: ZrO2: 15.5% to 22%; SiO2: 10.5% to 15%; Na2O+K2O+Li2O: 1.0% to 2.5%; impurities: <1%. Application to glass furnaces, in particular to the superstructures and crowns thereof.
Patent AU-2005290094-A1 (AU)
Title: RF ablation probe with unibody electrode element
Inventor: TEAGUE JAMES A
IPC: A61B18/14
Filed: 2005-08-23
Abstract: An ablation probe and method of manufacturing the ablation probe are provided. The probe comprises a probe shaft and a unibody electrode element. The unibody electrode element comprises a common electrode base located at the distal end of the shaft, and a plurality of electrode tines distally extending from the electrode base. The electrode element may be created by forming divisions (such as slits or slots) from a first end of an electrically conductive elongate member towards an opposing second end of the elongate member. Alternatively, the divisions can be formed from a first end of an electrically conductive sheet towards an opposing second end of the sheet, and then bent or rolled to form the elongate member. In either case, the common electrode base can either be separately mounted to a probe shaft, or the probe shaft can be formed from the elongate member, in which case, the electrode base will be integrated with the probe shaft as a unibody structure. The electrode tines can be optionally shaped, e.g., to proximally evert.
Patent AU-2005300589-A1 (AU)
Title: Banknotes with a printed security image that can be detected with one-dimensional signal processing
Inventor: KUTTER MARTIN
IPC: G06T1/00
Filed: 2005-10-12
Abstract: The present invention aims to propose a method to generate a security pattern to be embedded in an original image having the particularity that the detection of the security pattern can be achieved through a simple, low processing capability device.  The present invention proposes a method for generating a security image comprising an original image and a security pattern, characterized in that the security pattern has the form of a grating in which the lines width and/or the line spacing is modulated to embody a predefined data, the security image is generated by the modulation of at least one color of at least a part of the original image with the grating.
Patent AU-2005318424-A1 (AU)
Title: Quaternary ammonium salts as M3 antagonists
Inventor: COLLINGWOOD STEPHEN PAUL
IPC: C07D413/12
Filed: 2005-12-22
Abstract: Compounds of formula (I), in salt or zwitterionic form, wherein J, L, M, R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
Patent AU-2006202258-A1 (AU)
Title: Peelable Vacuum Skin Packaging
Inventor: BERBERT OTACILIO T
IPC: B65B11/52
Filed: 2006-05-30
Abstract: The present invention describes vacuum skin packages comprising a thermoplastic film and a polyester substrate wherein the thermoplastic film includes at least a first polymer layer having a first surface and an opposing second surface and comprises an ethylene/unsaturated ester copolymer, wherein the first surface has been surface treated in a manner to exhibit a surface tension of between 36-60 dynes/cm. The thermoplastic film is adapted to form a peelable seal between the first surface of the first polymer layer of the thermoplastic film and the polyester substrate by a pressure of less than 1 × 10 5  Pa applied therebetween, wherein the peelable seal has a seal strength of between 0.5-6 1b./in. (0.09-1.08 kg/cm).
Patent AU-2006213722-A1 (AU)
Title: 2-methylene-19-nor-(20S-24epi)-1alpha,25-dihydroxyvitamin-D2
Inventor: PLUM LORI A
IPC: C07C401/00
Filed: 2006-02-10
Abstract: Compounds of formula I are provided where X1, X2, and X3 are independently selected from H or hydroxy protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological conditions.
Patent AU-2006235967-A1 (AU)
Title: Tubulin binding ligands and corresponding prodrug constructs
Inventor: HADIMANI MALLINATH
IPC: C07D233/54
Filed: 2006-11-10
Abstract: A diverse set of tubulin binding ligands have been discovered which are structurally characterized, in a general sense, by a semi-rigid molecular framework capable of maintaining aryl-aryl, pseudo pi stacking distances appropriate for molecular recognition of tubulin. In phenolic or amino form, these ligands may be further functionalized to prepare phosphate esters, phosphate salts, and phosphoramidates capable of demonstrating selective targeting and destruction of tumor cell vasculature.
Patent AU-2006249349-A1 (AU)
Title: Oral dosage forms comprising progesterone and methods of making and using the same
Inventor: AHMED SALAH U
IPC: A61K9/16
Filed: 2006-05-26
Abstract: The present invention relates to an oral pharmaceutical dosage form comprising micronized progesterone, an edible oil, a disintegrant, and a hydrophilic excipient. Particularly, the invention relates to a pharmaceutical dosage form wherein the dosage form is in a powder form and is contained in a pharmaceutically acceptable capsule. The present invention is also directed toward methods of making the dosage form, methods of using the dosage form, and kits comprising the dosage form.
Patent AU-2006302672-A1 (AU)
Title: Composition and ink receiving system incorporating the composition
Inventor: KOENIG MICHAEL F
IPC: B41M5/50
Filed: 2006-09-25
Abstract: A composition includes an alkenyl succinic anhydride sizing agent or an alkyl ketene dimer sizing agent. The alkenyl succinic anhydride sizing agent is present in an amount ranging from about 1.0 pounds per ton to about 4.0 pounds per ton. The alkyl ketene dimer sizing agent is present in an amount ranging from about 2.0 pounds per ton to about 10.0 pounds per ton. A metallic salt is also incorporated in the composition.
Patent AU-2006311568-A1 (AU)
Title: Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
Inventor: TIAN FENG
IPC: C07K1/02
Filed: 2006-11-08
Abstract: Disclosed herein are accelerants for the formation of oxime-containing compounds from the reaction of a carbonyl-containing compound and a hydroxylamine-containing compound. The oxime-containing compound, the carbonyl-containing compound and the hydroxylamine-containing compound can each be a non-natural amino acid or a non-natural amino acid polypeptide. Also disclosed is the use of such accelerants to form oxime-containing compounds, the resulting oxime-containing compounds, and reaction mixtures containing such accelerants.
Patent WO-2008067606-A1 (WO)
Title: Procédé et appareil pour doter un produit d'un fini de surface désiré
Inventor: GARROW DONALD JAMES
IPC: B05B14/48
Filed: 2007-12-06
Abstract: L'invention concerne un procédé et un appareil destinés à doter des produits d'un fini de surface désiré. Sous une forme, l'invention concerne un procédé et un appareil destinés à doter un produit d'un revêtement de surface de vernis d'impression. Sous une forme privilégiée, l'invention concerne un procédé et un appareil destinés à doter un produit en mousse d'un revêtement de surface de vernis d'impression de polyuréthane incorporant une matière particulaire, telle que du sable, de façon à fournir un fini de surface texturé. L'appareil (1) comprend un ensemble (4) de chambre de pulvérisation, un applicateur (5) de matière particulaire, un décapant (6) de matière particulaire, un système transporteur (13-20), un compartiment (7) de collecte de matière particulaire et un système (8) de récupération de matière particulaire.
Patent AU-2007201711-A1 (AU)
Title: Methods and Compositions Using Stearoyl-CoA Desaturase to Identify Triglyceride Reducing Therapeutic Agents
Inventor: GRAY-KELLER MARK P
IPC: C12N1/21
Filed: 2007-04-18
Abstract: The use of screening assays based on the role of human stearoyl-CoA desaturase-1 ("hSCD1") in human diseases, disorders or conditions relating to serum levels of triglyceride, VLDL, HDL, LDL, total cholesterol, or production of secretions from mucous membranes, monounsaturated fatty acids, wax esters, and the like, is disclosed. Also disclosed are conventions useful in the prevention and/or treatment of such diseases.
Patent AU-2007211885-A1 (AU)
Title: Bearing material of medical implant and method for making it
Inventor: KING RICHARD S
IPC: A61L27/26
Filed: 2007-08-22
Abstract: A bearing component of a medical implant is formed from an ultrahigh molecular weight polyethylene (UHMWPE) composite which comprises UHMWPE and a polyethylene copolymer having a polymer backbone and pendant hydrophilic groups or pendant surface active agents that are attached to the polymer backbone. The bearing material can exhibit reduced immune response and wear, and increased lubrication.
Patent AU-2007287602-A1 (AU)
Title: Process for coating a hot- or cold-rolled steel strip containing 6 - 30% by weight of Mn with a metallic protective layer
Inventor: LEUSCHNER RONNY
IPC: C23C2/02
Filed: 2007-08-20
Abstract: A method for coating hot-rolled or cold-rolled steel strip containing 6-30 wt %. Mn with a metallic protective layer, includes annealing the steel strip at a temperature of 800-1100° C. under an annealing atmosphere containing nitrogen, water and hydrogen and then subjecting the steel strip to hot dip coating. The method provide an economical way of hot dip coating a high manganiferous sheet steel in that, in order to produce a metallic protective layer substantially free from oxidic sub-layers on the steel strip, the % H2O/% H2 ratio of the water content % H2O to the hydrogen content % H2 in the annealing atmosphere is adjusted as a function of the respective annealing temperature TG as follows: % H2O/% H2≰8·10−15·TG3.529.
Patent AU-2007311652-A1 (AU)
Title: Abnormal event detection using principal component analysis
Inventor: LANDELLS KEITH
IPC: G06F17/18
Filed: 2007-10-16
Abstract: A method for detecting abnormal events in a process comprising one or more independent variables and one or more dependent variables, means for measuring values of the one or more dependent and independent variables, and a multivariable predictive control means capable of calculating predicted values of the one or more dependent variables from the measured values of the one or more independent variables, which method comprises calculating residual values for the one or more dependent variables from the difference between the predicted and measured values of the one or more dependent variables, and performing principal component analysis on the residual values. The means for measuring values of the one or more dependent and independent variables and the multivariable predictive control means can be part of a system which also comprises means for calculating residual values for the one or more dependent variables from the difference between the measured and predicted values, and a means for performing principal components analysis on the residual values.
Patent AU-2007328210-A1 (AU)
Title: Intermediate duration neuromuscular blocking agents and antagonists thereof
Inventor: SAVARESE JOHN J
IPC: A61K31/47
Filed: 2007-12-05
Abstract: The invention provides novel neuromuscular blocking agents, methods of using the neuromuscular blocking agents as well as reagents, methods and kits for reversing the effects of the neuromuscular blocking agents.
Patent AU-2007338360-A1 (AU)
Title: Method for purifying RNA on a preparative scale by means of HPLC
Inventor: REIDEL LADISLAUS
IPC: C12N15/10
Filed: 2007-12-20
Abstract: The application describes a method for the preparative purification of RNA, which method is distinguished in that the RNA is purified by means of HPLC using a porous reversed phase as the stationary phase. The use of the porous reversed phase in this HPLC method is also described.
Patent WO-2009055872-A1 (WO)
Title: Liaison photonique déployable et module d'interface
Inventor: BRADBURY IAN
IPC: H04B10/00
Filed: 2008-10-31
Abstract: L'invention porte sur une liaison photonique déployable, comprenant un segment déployable de fibre optique et un module d'interface épissé par fusion à au moins une extrémité de la fibre optique de sorte que le module est directement connecté à la fibre. Le module d'interface comprend au moins un élément parmi : une entrée pour recevoir un premier signal électrique comprenant une première composante de signal radiofréquence (RF) ; et une sortie pour délivrer une seconde composante de signal RF. Le module d'interface comprend en outre, respectivement, au moins : un dispositif pour recevoir le premier signal électrique provenant de l'entrée et pour produire un signal optique modulé avec la première composante de signal RF pour une transmission dans la fibre optique ; et un dispositif pour recevoir un signal optique modulé et pour produire à partir de celui-ci la seconde composante de signal RF pour la délivrer à la sortie. Un module d'interface peut aussi contenir à la fois l'entrée et la sortie et les dispositifs pour recevoir des signaux RF et pour recevoir des signaux optiques modulés.